Home > Insider Trading > Filing (0001437749-14-001663)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484478	Furiex Pharmaceuticals Inc.	FURX	Pharmaceutical Preparations (2834)	271197863

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1492647	Sherie June Almenoff	C/O Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150 Morrisville NC 27560	President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-04	27,000	$9.11	51,600	No	4	M	Direct
Common Stock	Acquisiton	2014-02-04	21,718	$9.11	73,318	No	4	M	Direct
Common Stock	Acquisiton	2014-02-04	19,000	$15.00	92,318	No	4	M	Direct
Common Stock	Acquisiton	2014-02-04	43,939	$13.16	136,257	No	4	M	Direct
Common Stock	Acquisiton	2014-02-04	3,456	$17.80	139,713	No	4	M	Direct
Common Stock	Disposition	2014-02-04	93,395	$114.60	46,318	No	4	S	Direct
Common Stock	Disposition	2014-02-04	21,718	$118.25	24,600	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (to buy)	Disposition	2014-02-04	27,000	$0.00	27,000	$9.11
Common Stock	Stock Options (to buy)	Disposition	2014-02-04	21,718	$0.00	21,718	$9.11
Common Stock	Stock Options (to buy)	Disposition	2014-02-04	19,000	$0.00	19,000	$15.00
Common Stock	Stock Options (to buy)	Disposition	2014-02-04	43,939	$0.00	43,939	$13.16
Common Stock	Stock Options (to buy)	Disposition	2014-02-04	3,456	$0.00	3,456	$17.80

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
104,718	2020-06-17	No	4	M	Direct
83,000	2020-06-17	No	4	M	Direct
27,000	2021-05-09	No	4	M	Direct
21,970	2021-10-03	No	4	M	Direct
6,912	2022-02-24	No	4	M	Direct

Footnotes

The exercise and sale were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person dated September 6, 2013.
The exercise and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated December 5, 2013.
The options were awarded on 6/17/2010 and vested over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 5/9/2011. One-third of the options vested on the date of grant and the remaining two-thirds vested in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 2/24/2012 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.